Ascending pain pathway is inhibited in dorsal midbrain by encephalin anda) 5-HT (serotonin)b) Noradrenalinec) Substance Pd) Glutamatee) Adenosine

**Core Concept**
The ascending pain pathway is a complex neural network that transmits pain signals from the body to the brain. The dorsal midbrain is a crucial region where pain modulation occurs, involving various neurotransmitters and their receptors.

**Why the Correct Answer is Right**
Enkephalins, natural opioids, are released in the dorsal midbrain and inhibit the ascending pain pathway. They act on opioid receptors, specifically μ-opioid receptors, to reduce pain transmission. This mechanism is a key component of pain modulation and is exploited by opioid analgesics. Enkephalins work by binding to opioid receptors on the terminals of nociceptive neurons, thereby reducing the release of pain-transmitting neurotransmitters such as substance P.

**Why Each Wrong Option is Incorrect**
* **Option A:** 5-HT (serotonin) is involved in mood regulation and has some analgesic effects, but it is not the primary inhibitor of the ascending pain pathway in the dorsal midbrain.
* **Option B:** Noradrenaline (norepinephrine) is a neurotransmitter involved in attention and arousal, but it is not directly involved in pain inhibition in the dorsal midbrain.
* **Option C:** Substance P is actually a pain-transmitting neurotransmitter, not an inhibitor of the ascending pain pathway.
* **Option D:** Glutamate is an excitatory neurotransmitter involved in various physiological processes, but it is not an inhibitor of the ascending pain pathway in the dorsal midbrain.
* **Option E:** Adenosine has some analgesic effects, but it is not the primary inhibitor of the ascending pain pathway in the dorsal midbrain.

**Clinical Pearl / High-Yield Fact**
Opioid receptors, including μ-opioid receptors, are a key target for pain management. Understanding the mechanisms of opioid analgesia is crucial for developing effective pain treatment strategies.

**Correct Answer:** C. Substance P